Des Plaines, Illinois – Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.
Author: OphthalmologyWeb
Roche’s Lucentis Helps Diabetics’ Vision
Diabetics suffering from a complication that can cause blindness can see better when treated with Roche’s eye drug Lucentis, giving the medicine a slight lift ahead of another keenly awaited trial.
New Microscope Decodes Complex Eye Circuitry
The properties of optical stimuli need to be conveyed from the eye to the brain. To do this efficiently, the relevant information is extracted by pre-processing in the eye.
Repeatable SLT Has Similar IOP Reductions After Each Treatment
In a study of selective laser trabeculoplasty, researchers found that the practice is not only repeatable but also has similar pressure reduction results after each treatment.
New Microscope Decodes Complex Eye Circuitry
The properties of optical stimuli need to be conveyed from the eye to the brain. To do this efficiently, the relevant information is extracted by pre-processing in the eye.
FDA Approves New Cataract Multifocal Intraocular Lens From Abbott
Des Plaines, Illinois – Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.
Roche’s Lucentis Helps Diabetics’ Vision
Diabetics suffering from a complication that can cause blindness can see better when treated with Roche’s eye drug Lucentis, giving the medicine a slight lift ahead of another keenly awaited trial.
Repeatable SLT Has Similar IOP Reductions After Each Treatment
In a study of selective laser trabeculoplasty, researchers found that the practice is not only repeatable but also has similar pressure reduction results after each treatment.
STAAR Surgical Enters Into Distribution Agreement With Ellex In Australia
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has entered into an agreement with Ellex Australia for the exclusive distribution of STAAR intraocular lenses in …
STAAR Surgical Enters Into Distribution Agreement With Ellex In Australia
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has entered into an agreement with Ellex Australia for the exclusive distribution of STAAR intraocular lenses in …
Kowa Optimed Receives 510(k) Clearance For NonmydT WX3D
Torrance, CA – Kowa Optimed, Inc., is part of a multi-faceted global company providing products and services to diverse markets, recently announced that they have received 501(k) approval from the U.S. Food and Drug Administration (FDA) for the marketi…
Kowa Optimed Receives 510(k) Clearance For NonmydT WX3D
Torrance, CA – Kowa Optimed, Inc., is part of a multi-faceted global company providing products and services to diverse markets, recently announced that they have received 501(k) approval from the U.S. Food and Drug Administration (FDA) for the marketi…
Kowa Optimed Receives 510(k) Clearance For NonmydT WX3D
Torrance, CA – Kowa Optimed, Inc., is part of a multi-faceted global company providing products and services to diverse markets, recently announced that they have received 501(k) approval from the U.S. Food and Drug Administration (FDA) for the marketi…
Tube Shunt Surgery More Successful Than Trabeculectomy With MMC, Study Shows
Tube shunt surgery had a higher success rate than trabeculectomy with mitomycin C after 5 years of follow-up in the Tube Versus Trabeculectomy Study, a researcher reported here.
Kowa Optimed Receives 510(k) Clearance For NonmydT WX3D
Torrance, CA – Kowa Optimed, Inc., is part of a multi-faceted global company providing products and services to diverse markets, recently announced that they have received 501(k) approval from the U.S. Food and Drug Administration (FDA) for the marketi…
Tube Shunt Surgery More Successful Than Trabeculectomy With MMC, Study Shows
Tube shunt surgery had a higher success rate than trabeculectomy with mitomycin C after 5 years of follow-up in the Tube Versus Trabeculectomy Study, a researcher reported here.
Kowa Optimed Receives 510(k) Clearance For NonmydT WX3D
Torrance, CA – Kowa Optimed, Inc., is part of a multi-faceted global company providing products and services to diverse markets, recently announced that they have received 501(k) approval from the U.S. Food and Drug Administration (FDA) for the marketi…
Additional Support For Ophthalmic Applications For Laser Technology Using The Company’s Er,Cr:YSGG Waterlase Technology
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, today announced that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating va…
Clustering Gene Expression Changes Reveals Pathways Toward Glaucoma Prevention
Glaucoma is the second-most common cause of blindness in the US, and occurs due to loss of retinal ganglion cells and degeneration of the optic nerve. Although it is known that high levels of pressure within the eye predispose individuals to the develo…
Additional Support For Ophthalmic Applications For Laser Technology Using The Company’s Er,Cr:YSGG Waterlase Technology
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, today announced that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating va…